Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial

Chest. 2003 Oct;124(4):1312-7. doi: 10.1378/chest.124.4.1312.

Abstract

Study objective: We conducted the first randomized controlled study to assess the effects of short-term 28% and 100% oxygen on PaCO(2) and peak expiratory flow rate (PEFR) in patients with acute severe asthma.

Patients and interventions: Seventy-four patients (mean age, 37.9 +/- 9.7 years [+/- SD]; PEFR, 41.0 +/- 12.1% of predicted) from two emergency departments were randomized to receive 28% or 100% oxygen during 20 min.

Results: The administration of 100% oxygen significantly increases PaCO(2) (p = 0.03) and decreases PEFR (p = 0.001) as compared with administration of 28% oxygen. PaCO(2) before and during oxygen administration correlated significantly (p = 0.001) in both groups. Patients breathing 28% oxygen experienced a PaCO(2) fall; on the contrary, patients who received 100% oxygen showed an increase in PaCO(2), particularly those with PaCO(2) before oxygen treatment > 40 mm Hg.

Conclusions: This study confirmed previous observations that oxygen dose should be variable and based on achieving and maintaining target arterial oxygen saturation measured by pulse oximetry > or = 92% rather than on prescribing predetermined concentrations or flow rates of inspired oxygen.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adult
  • Asthma / blood
  • Asthma / drug therapy*
  • Asthma / physiopathology*
  • Blood Gas Analysis
  • Carbon Dioxide / blood
  • Female
  • Humans
  • Male
  • Oxygen / administration & dosage*
  • Oxygen / pharmacology
  • Peak Expiratory Flow Rate / drug effects
  • Severity of Illness Index
  • Time Factors

Substances

  • Carbon Dioxide
  • Oxygen